eConsent audit trails for clinical trials: what sites should verify before enrollment

Electronic consent can make a research workflow easier to manage, but it also creates a clear documentation question: can the site reconstruct what the participant saw, when they saw it, who answered questions, and which version was signed?

FDA and OHRP guidance describes electronic informed consent as a process that may use multiple electronic media. That process still needs to satisfy the applicable informed consent, IRB, and electronic records requirements for the study.

The operational risk is assuming that a signed electronic document proves the whole process. A monitor or sponsor may need more: version history, identity controls, timestamps, signature linkage, and a clean amendment path.

Start with identity and role. The record should show who signed, who administered or reviewed the consent step, and whether a witness or legally authorized representative workflow applied.

Next, verify version control. Every participant should be tied to the exact IRB-approved consent version active at the time of signature. If the system stores signed forms as generic attachments, the site may struggle to prove which version was used.

Then check event timing. The audit trail should show when the participant opened, reviewed, signed, declined, restarted, or completed the process. That timing should remain readable after export or archival.

Consider a three-study site that moves from paper packets to an eConsent tool. The first week looks efficient because coordinators no longer chase scanned documents. Then an amendment is approved and the site realizes amended consent files are being uploaded with generic filenames.

During a monitoring review, the sponsor asks which participants saw version 3 and which saw version 4. The site can answer only after manually comparing upload dates, coordinator notes, and file names. The issue is not the concept of eConsent; it is weak audit trail design.

A better workflow locks signed records, names the consent version, separates original consent from re-consent, and creates a weekly exception report for participants who may need updated consent review.

Recruitment teams still need consent-readiness visibility. Coordinators should know whether a candidate is pending consent, consent completed, re-consent needed, declined, or not moving forward.

That does not mean the recruitment queue should store sensitive document contents. A safer operating pattern is to track status, owner, blocker, and next action in the recruitment workflow while the validated eConsent or document system remains the record source.

TrialsNest can support that operating view by keeping recruitment movement, records readiness, and next actions visible without turning the recruiting queue into an uncontrolled document repository.